SOX-based CRT for Esophageal Cancer.

NCT03991104 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No eligible patients enrolled. We have to withdraw the trial.

Conditions

Esophageal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: S-1 capsule
RADIATION: Intensity modulated radiotherapy (IMRT)

Sponsor

Zhejiang Provincial People's Hospital